The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Isoprenaline hydrochloride Macure 0.2 mg/ml concentrate for solution for infusion

Macure Pharma ApSPA23199/001/001

Main Information

Trade NameIsoprenaline hydrochloride Macure 0.2 mg/ml concentrate for solution for infusion
Dosage FormConcentrate for solution for infusion
Licence HolderMacure Pharma ApS
Licence NumberPA23199/001/001

Group Information

ATC CodeC01CA02 isoprenaline


License statusAuthorised
Licence Issued23/07/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licencerestricted for use by cardiologists or by physicians under the direct supervision of a cardiologist. Requires ECG monitoring during use, see section 4.4 of the SPC Precautions for use.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back